ロード中...
Efficacy of UK-49,858 (fluconazole) against Candida albicans experimental infections in mice.
UK-49,858 (fluconazole), a new, orally absorbed bis-triazole derivative, has been evaluated against systemic infections with Candida albicans in normal and immunosuppressed mice and against an intestinal infection with C. albicans in immunosuppressed mice. Orally administered ketoconazole was used a...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
1985
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC180335/ https://ncbi.nlm.nih.gov/pubmed/3002246 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|